BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23930488)

  • 1. Clinical characteristics of patients with hematological malignancies at gondar university hospital, North West Ethiopia.
    Weldetsadik AT
    Ethiop Med J; 2013 Jan; 51(1):25-31. PubMed ID: 23930488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-AIDS-defining hematological malignancies in HIV-infected patients: an epidemiological study in Japan.
    Hagiwara S; Yotsumoto M; Odawara T; Ajisawa A; Uehira T; Nagai H; Tanuma J; Okada S
    AIDS; 2013 Jan; 27(2):279-83. PubMed ID: 23014520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of hematological and non-hematological malignancies in bone marrow in a tertiary care hospital in Nepal--11 years study.
    Ghartimagar D; Ghosh A; Narasimhan R; Talwar OP
    Nepal Med Coll J; 2012 Sep; 14(3):187-92. PubMed ID: 24047012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experience with sixty cases of haematological malignancies; a clinico haematological correlation.
    Idris M; Shah SH; Fareed J; Gul N
    J Ayub Med Coll Abbottabad; 2004; 16(4):51-4. PubMed ID: 15762065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of hematological malignancies and peripheral cytopenias.
    Jha A
    J Nepal Health Res Counc; 2013 Sep; 11(25):273-8. PubMed ID: 24908530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five years review of cases of adult tetanus managed at Gondar University Hospital, North West Ethiopia (Gondar, Sep. 2003-Aug. 2008).
    Tadesse A; Gebre-Selassie S
    Ethiop Med J; 2009 Oct; 47(4):291-7. PubMed ID: 20067144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis.
    Sari I; Altuntas F; Hacioglu S; Kocyigit I; Sevinc A; Sacar S; Deniz K; Alp E; Eser B; Yildiz O; Kaynar L; Unal A; Cetin M
    Am J Hematol; 2008 Apr; 83(4):334-9. PubMed ID: 18069671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years.
    Elidrissi Errahhali M; Elidrissi Errahhali M; Boulouiz R; Ouarzane M; Bellaoui M
    BMC Cancer; 2016 Feb; 16():159. PubMed ID: 26915519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of haematologic malignancies and survival outcomes of adult lymphomas in Maiduguri, north eastern Nigeria--a fourteen year review.
    Kagu MB; Ahmed SG; Bukar AA; Mohammed AA; Mayun AA; Musa AB
    Afr J Med Med Sci; 2013 Mar; 42(1):5-14. PubMed ID: 23909089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program.
    Pagano L; Girmenia C; Mele L; Ricci P; Tosti ME; Nosari A; Buelli M; Picardi M; Allione B; Corvatta L; D'Antonio D; Montillo M; Melillo L; Chierichini A; Cenacchi A; Tonso A; Cudillo L; Candoni A; Savignano C; Bonini A; Martino P; Del Favero A; ;
    Haematologica; 2001 Aug; 86(8):862-70. PubMed ID: 11522544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematological malignancies in the island of Sardinia, 1974-1993: age and sex distributions and temporal changes in incidence.
    Broccia G; Deplano W; Dessalvi P; Giannico B; Luxi G; Chessa E; Murru A
    Hematol Oncol; 2004 Sep; 22(3):91-109. PubMed ID: 15991220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper levels in patients with hematological malignancies.
    Kaiafa GD; Saouli Z; Diamantidis MD; Kontoninas Z; Voulgaridou V; Raptaki M; Arampatzi S; Chatzidimitriou M; Perifanis V
    Eur J Intern Med; 2012 Dec; 23(8):738-41. PubMed ID: 22920946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic inactivation of the miR-34a in hematological malignancies.
    Chim CS; Wong KY; Qi Y; Loong F; Lam WL; Wong LG; Jin DY; Costello JF; Liang R
    Carcinogenesis; 2010 Apr; 31(4):745-50. PubMed ID: 20118199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-lymphoma hematological malignancies in systemic lupus erythematosus.
    Lu M; Bernatsky S; Ramsey-Goldman R; Petri M; Manzi S; Urowitz MB; Gladman D; Fortin PR; Ginzler EM; Yelin E; Bae SC; Wallace DJ; Jacobsen S; Dooley MA; Peschken CA; Alarcón GS; Nived O; Gottesman L; Criswell LA; Sturfelt G; Dreyer L; Lee JL; Clarke AE
    Oncology; 2013; 85(4):235-40. PubMed ID: 24107608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological malignancies in the Northwest Ethiopia.
    Enawgaw B; Aynalem M; Melku M; Asrie F; Abebe M; Yalew A; Bekele T; Mesfin N; Ayalew M; Shiferaw E
    PLoS One; 2021; 16(12):e0260639. PubMed ID: 34852010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.